Todd Lieberman

Angel investor in Pennsylvania · United States

Invests in AI

Todd Lieberman's investor profile lists AI alongside Healthcare & Biotech, Biotech & Pharma and SaaS & Enterprise, at pre-seed and seed. The record holds 5 deals, among them Sales Crunch, Crunched and Heyzap.

Email Investor

Email Investor

Credits to line up before a pre-seed round

Todd Lieberman backs companies at pre-seed and seed. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Sales Crunch
  • Crunched
  • Heyzap
  • Compound
  • Deduce

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, Biotech & Pharma, SaaS & Enterprise, Consumer & Retail, Developer Tools & Data and 5 more
Rounds
Pre-seed, Seed
Profile
Angel investor
Deals on record
5
Based in
United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Todd Lieberman invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Todd Lieberman's investor profile, together with Healthcare & Biotech, Biotech & Pharma and SaaS & Enterprise. The stages on record are pre-seed and seed.
Which companies has Todd Lieberman backed?
The record lists 5 deals, including Sales Crunch, Crunched, Heyzap, Compound and Deduce. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Todd Lieberman?
For a company raising a pre-seed round, AI Perks lists credits such as Gemini (up to $350,000), Appwrite (up to $20,000), Redis (up to $10,000) and Azure OpenAI (up to $150,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor